Transgene
TNG | PA
Overview
Corporate Details
- ISIN(s):
- FR0005175080
- LEI:
- 969500PDJW8N0FSGGK69
- Country:
- France
- Address:
- 400 BOULEVARD GONTHIER D'ANDERNACH, 67400 ILLKIRCH-GRAFFENSTADEN
- Website:
- https://www.transgene.fr/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Transgene is a publicly traded French biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. A pioneer in viral vectors engineering, we have one ambition: design innovative treatments in the fight against cancer. Our approach uses the mechanisms of the immune response to enable the patient’s body to fight against disease.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-09 17:45 |
Board/Management Change
Transgene nomme une experte de l’industrie pharmaceutique, Emmanuelle Quilès, e…
|
French | 387.4 KB | |
| 2025-07-09 17:45 |
Board/Management Change
Transgene Appoints Seasoned Industry Executive Emmanuelle Quilès to Board of Di…
|
English | 255.1 KB | |
| 2025-06-19 08:00 |
Regulatory News Service
Transgene Completes Initial Patient Screening in Phase II Part of TG4050 Trial …
|
English | 310.5 KB | |
| 2025-06-19 08:00 |
Regulatory News Service
Transgene finalise la sélection initiale de patients pour la partie Phase II de…
|
French | 304.7 KB | |
| 2025-06-13 08:30 |
Regulatory News Service
Transgene participera à plusieurs rencontres avec des acteurs clés de la biotec…
|
French | 304.7 KB | |
| 2025-06-13 08:30 |
Regulatory News Service
Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders
|
English | 277.0 KB | |
| 2025-06-03 08:00 |
Regulatory News Service
Transgene organise un webinaire sur les résultats positifs de TG4050 dans les c…
|
French | 269.2 KB | |
| 2025-06-03 08:00 |
Regulatory News Service
Transgene to Host Webcast on Positive TG4050 Head and Neck Cancer Data Presente…
|
English | 282.5 KB | |
| 2025-06-01 19:15 |
Regulatory News Service
Transgene et NEC présentent une survie sans récidive durable, accompagnée d’une…
|
French | 378.8 KB | |
| 2025-06-01 19:15 |
Regulatory News Service
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Re…
|
English | 394.4 KB | |
| 2025-05-22 17:45 |
Regulatory News Service
Transgene présente des données de survie sans récidive à 24 mois sur l’ensemble…
|
French | 378.1 KB | |
| 2025-05-22 17:45 |
Regulatory News Service
Transgene to Present 24-month Disease-Free Survival Data from All Patients in P…
|
English | 412.3 KB | |
| 2025-05-15 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Assemblée Générale Mixte de Transgene du 15 mai 2025
|
French | 315.4 KB | |
| 2025-05-15 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Transgene's Combined General Meeting of May 15, 2025
|
English | 285.9 KB | |
| 2025-04-24 17:45 |
Quarterly Report
Transgene Provides Business and Financial Update for Q1 2025
|
English | 310.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-30 | N/A | Other | Other | 30,898,876 | 32,999,999.57 EUR |
| 2023-05-26 | N/A | Other | Buy | 29,325 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |